Table 3 Additional HLA-B alleles that are significantly increased or decreased in the psoriatic arthritis cohort
From: Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
HLA allele | PsA (%), n  = 359 | PsA versus control | PsO (%), n  = 214 | PsO versus control | Control (%), n  = 1,000 | PsA versus PsO |
|---|---|---|---|---|---|---|
B*27:05 | 15.6 | 2.6 (1.7 to 4.2) | 4.7 | P = 0.23 | 5.5 | 3.77 (1.9 to 7.6) |
B*39:01 | 6.4 | 3.5 (1.6 to 7.6) | 1.4 | P = 1 | 1.2 | 2.86 (1.1 to 7.6) |
B*08:01 | 37.3 | 1.6 (1.2 to 2.0) | 24.8 | 0.43 (0.25 to 0.76) | 30.1 | 1.81 (1.6 to 6.5) |
B*44:02 | 14.8 | 0.53 (0.36 to 0.80) | 22.4 | P = 0.7 | 24.6 | 0.60 (0.29 to 0.87) |